Psoriasis Research Review, Issue 27

In this Issue:

Ixekizumab for moderate-to-severe plaque psoriasis
Baricitinib for moderate-to-severe psoriasis
JAK inhibitor INCB039110 in chronic plaque psoriasis
Psoriasis and adverse pregnancy outcomes
Family history predicts MACE in young adults with psoriasis
Clinical meaningfulness of complete skin clearance
Apremilast effective in palmoplantar psoriasis
Anxiety and depression in Singaporean psoriasis patients
Biologic drug survival in a large psoriasis registry
TNF-α inhibitor therapy and cardiovascular disease

 

Please login below to download this issue (PDF)

Subscribe